Pulmonary Manifestations in Patients with Dermatomyositis - Effect of IVIG Treatment: Data from the ProDERM Study (P3-11.011)
Post-hoc analysis to assess the effect of intravenous immunoglobulin (IVIg) on pulmonary symptoms of dermatomyositis (DM).
Authors
- Joachim Schessl
- Rohit Aggarwal (ORCID: https://orcid.org/0000-0001-7531-8038)
- Christina Charles‐Schoeman (ORCID: https://orcid.org/0000-0002-1768-7019)
- Elisabeth Clodi
- Mazen M. Dimachkie (ORCID: https://orcid.org/0000-0002-7148-989X)
Institutions
- University of Pittsburgh (US)
- UCLA Health (US)
- Octapharma (Austria) (AT)
- University of Kansas Medical Center (US)
- Friedrich Baur Stiftung (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208611
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00